BioRender 아이콘

Microfluidic device (step emulsification, partial cross-section)

Microfluidic device (step emulsification, partial cross-section) - Editable icon of a zoom in of a partial cross section of a microfluidic device for step emulsification with 3 channels shown in a 3/4 view
[{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d54/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d54/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d53/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d53/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d52/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d52/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d51/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d51/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d50/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d50/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4f/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4f/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4e/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4e/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4d/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4d/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4c/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4c/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4b/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4b/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d4a/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d4a/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d49/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d49/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d48/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d48/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d47/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d47/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d46/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d46/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d45/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d45/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d44/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d44/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d43/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d43/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d42/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d42/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d41/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d41/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d40/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d40/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3f/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3f/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3e/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3e/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3d/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3d/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3c/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3c/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3b/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3b/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d3a/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d3a/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d39/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d39/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d38/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d38/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d37/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d37/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d36/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d36/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d35/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d35/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d34/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d34/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d33/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d33/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d32/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d32/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d31/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d31/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d30/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d30/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d2f/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d2f/64063ecb97c2ea0020512d2d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64063f5997c2ea0020512d2e/64063ecb97c2ea0020512d2d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64063f5997c2ea0020512d2e/64063ecb97c2ea0020512d2d.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍
page dashboard

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
microfluidic,device,step,emulsification,parallelized,microchannel,microparticle,particle,hydrogel,chip,oil,slide,liquid,phase-separation,polymerizable,cells,tissues,cellular,fabricate,polyethylene,glycol,PEG,gelatin,aqueous,two-phase,system,ATPS,droplets,cross-linked,nanovials,cavity,sorting,liquid,slide,chip,oil,spontaneous transformation mechanisms,bubble formation,3/4,three-quarter,3D,three dimensional
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Microfluidic device (step emulsification, partial cross-section) icon JPEG

Microfluidic device (step emulsification, partial cross-section) icon PNG

Microfluidic device (step emulsification, partial cross-section) icon SVG

Microfluidic device (step emulsification, partial cross-section) icon GIF

BioRender 아이콘 FAQ

How are scientists using the Microfluidic device (step emulsification, partial cross-section) icon in their work?

BioRender users often use the Microfluidic device (step emulsification, partial cross-section) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Microfluidic device (step emulsification, partial cross-section) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Microfluidic device (step emulsification, partial cross-section) icon customizable in BioRender?

Most icons in BioRender, including the Microfluidic device (step emulsification, partial cross-section) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Microfluidic device (step emulsification, partial cross-section) icon for publication or presentations?

Yes, figures containing the Microfluidic device (step emulsification, partial cross-section) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Microfluidic device (step emulsification, partial cross-section) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Microfluidic device (step emulsification, partial cross-section) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Microfluidic device (step emulsification, partial cross-section) icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon